Pten in stromal fibroblasts suppresses mammary epithelial tumours (original) (raw)

• Wiseman, B. S. & Werb, Z. Stromal effects on mammary gland development and breast cancer. Science 296, 1046–1049 (2002)
  Article ADS CAS Google Scholar
• Nelson, C. M. & Bissell, M. J. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 22, 287–309 (2006)
  Article CAS Google Scholar
• Mueller, M. M. & Fusenig, N. E. Friends or foes – bipolar effects of the tumour stroma in cancer. Nature Rev. Cancer 4, 839–849 (2004)
  Article CAS Google Scholar
• Schedin, P. Pregnancy-associated breast cancer and metastasis. Nature Rev. Cancer 6, 281–291 (2006)
  Article CAS Google Scholar
• Littlepage, L. E., Egeblad, M. & Werb, Z. Coevolution of cancer and stromal cellular responses. Cancer Cell 7, 499–500 (2005)
  Article CAS Google Scholar
• Bhowmick, N. A., Neilson, E. G. & Moses, H. L. Stromal fibroblasts in cancer initiation and progression. Nature 432, 332–337 (2004)
  Article ADS CAS Google Scholar
• Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nature Rev. Cancer 6, 392–401 (2006)
  Article CAS Google Scholar
• Cully, M., You, H., Levine, A. J. & Mak, T. W. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nature Rev. Cancer 6, 184–192 (2006)
  Article CAS Google Scholar
• Bergamaschi, A. et al. Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. J. Pathol. 214, 357–367 (2008)
  Article CAS Google Scholar
• Myers, M. P. et al. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc. Natl Acad. Sci. USA 95, 13513–13518 (1998)
  Article ADS CAS Google Scholar
• Stambolic, V. et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29–39 (1998)
  Article CAS Google Scholar
• Salmena, L., Carracedo, A. & Pandolfi, P. P. Tenets of PTEN tumor suppression. Cell 133, 403–414 (2008)
  Article CAS Google Scholar
• Knobbe, C. B., Lapin, V., Suzuki, A. & Mak, T. W. The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey. Oncogene 27, 5398–5415 (2008)
  Article CAS Google Scholar
• Di Cristofano, A., Pesce, B., Cordon-Cardo, C. & Pandolfi, P. P. Pten is essential for embryonic development and tumour suppression. Nature Genet. 19, 348–355 (1998)
  Article CAS Google Scholar
• Trimboli, A. J. et al. Direct evidence for epithelial–mesenchymal transitions in breast cancer. Cancer Res. 68, 937–945 (2008)
  Article CAS Google Scholar
• Guy, C. T. et al. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl Acad. Sci. USA 89, 10578–10582 (1992)
  Article ADS CAS Google Scholar
• Cases, S. et al. Development of the mammary gland requires DGAT1 expression in stromal and epithelial tissues. Development 131, 3047–3055 (2004)
  Article CAS Google Scholar
• Andrechek, E. R. et al. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc. Natl Acad. Sci. USA 97, 3444–3449 (2000)
  Article ADS CAS Google Scholar
• Desai, K. V. et al. Initiating oncogenic event determines gene-expression patterns of human breast cancer models. Proc. Natl Acad. Sci. USA 99, 6967–6972 (2002)
  Article ADS CAS Google Scholar
• Mootha, V. K. et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genet. 34, 267–273 (2003)
  Article ADS CAS Google Scholar
• Dennis, G. et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4, 3 (2003)
  Article Google Scholar
• Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 4, 44–57 (2009)
  Article CAS Google Scholar
• Weng, L. P., Brown, J. L., Baker, K. M., Ostrowski, M. C. & Eng, C. PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway. Hum. Mol. Genet. 11, 1687–1696 (2002)
  Article CAS Google Scholar
• Fowles, L. F. et al. Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling. Mol. Cell. Biol. 18, 5148–5156 (1998)
  Article CAS Google Scholar
• McCarthy, S. A. et al. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol. Cell. Biol. 17, 2401–2412 (1997)
  Article CAS Google Scholar
• Smith, J. L. et al. ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice. Mol. Cell. Biol. 20, 8026–8034 (2000)
  Article CAS Google Scholar
• Watabe, T. et al. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int. J. Cancer 77, 128–137 (1998)
  Article CAS Google Scholar
• Wei, G. et al. Activated Ets2 is required for persistent inflammatory responses in the motheaten viable model. J. Immunol. 173, 1374–1379 (2004)
  Article CAS Google Scholar
• Ludwig, T. Local proteolytic activity in tumor cell invasion and metastasis. Bioessays 27, 1181–1191 (2005)
  Article CAS Google Scholar
• Wei, G. et al. Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis. Blood 114, 1123–1130 (2009)
  Article CAS Google Scholar
• Lin, E. Y. et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol. 163, 2113–2126 (2003)
  Article Google Scholar
• Yamamoto, H. et al. Defective trophoblast function in mice with a targeted mutation of Ets2. Genes Dev. 12, 1315–1326 (1998)
  Article CAS Google Scholar
• Lee, S., Jilani, S. M., Nikolova, G. V., Carpizo, D. & Iruela-Arispe, M. L. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 169, 681–691 (2005)
  Article CAS Google Scholar
• Millauer, B. et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835–846 (1993)
  Article CAS Google Scholar
• Sakurai, Y., Ohgimoto, K., Kataoka, Y., Yoshida, N. & Shibuya, M. Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc. Natl Acad. Sci. USA 102, 1076–1081 (2005)
  Article ADS CAS Google Scholar
• Dakappagari, N. K. et al. Conformational HER-2/neu B-cell epitope peptide vaccine designed to incorporate two native disulfide bonds enhances tumor cell binding and antitumor activities. J. Biol. Chem. 280, 54–63 (2005)
  Article CAS Google Scholar
• Finak, G. et al. Stromal gene expression predicts clinical outcome in breast cancer. Nature Med. 14, 518–527 (2008)
  Article CAS Google Scholar
• Berns, K. et al. A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer. Cancer Cell 12, 395–402 (2007)
  Article CAS Google Scholar
• Saal, L. H. et al. Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nature Genet. 40, 102–107 (2008)
  Article CAS Google Scholar
• Saal, L. H. et al. Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity. Proc. Natl Acad. Sci. USA 104, 7564–7569 (2007)
  Article ADS CAS Google Scholar
• Tynan, J. A., Wen, F., Muller, W. J. & Oshima, R. G. Ets2-dependent microenvironmental support of mouse mammary tumors. Oncogene 24, 6870–6876 (2005)
  Article CAS Google Scholar
• Buggy, Y. et al. Ets2 transcription factor in normal and neoplastic human breast tissue. Eur. J. Cancer 42, 485–491 (2006)
  Article CAS Google Scholar
• Park, E. S. et al. Heterologous tissue culture expression signature predicts human breast cancer prognosis. PLoS One 2, e145 (2007)
  Article ADS Google Scholar
• Svensson, S. et al. ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis. Oncogene 24, 4370–4379 (2005)
  Article CAS Google Scholar
• Pap, T. et al. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res. 2, 59–64 (2000)
  Article CAS Google Scholar
• White, E. S. et al. Negative regulation of myofibroblast differentiation by PTEN (phosphatase and tensin homolog deleted on chromosome 10). Am. J. Respir. Crit. Care Med. 173, 112–121 (2006)
  Article CAS Google Scholar
• Gibson, G. E. & Huang, H. M. Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer’s disease. Front. Biosci. 7, d1007–d1015 (2002)
  CAS PubMed Google Scholar
• Allred, D. C., Harvey, J. M., Berardo, M. & Clark, G. M. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod. Pathol. 11, 155–168 (1998)
  CAS PubMed Google Scholar
• Soule, H. D. & McGrath, C. M. A simplified method for passage and long-term growth of human mammary epithelial cells. In Vitro Cell. Dev. Biol. 22, 6–12 (1986)
  Article CAS Google Scholar
• Soriano, P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nature Genet. 21, 70–71 (1999)
  Article CAS Google Scholar
• Mook, O. R., Van Overbeek, C., Ackema, E. G., Van Maldegem, F. & Frederiks, W. M. In situ localization of gelatinolytic activity in the extracellular matrix of metastases of colon cancer in rat liver using quenched fluorogenic DQ-gelatin. J. Histochem. Cytochem. 51, 821–829 (2003)
  Article CAS Google Scholar
• Auer, H. et al. Gene-resolution analysis of DNA copy number variation using oligonucleotide expression microarrays. BMC Genomics 8, 111 (2007)
  Article Google Scholar
• Hu, R. et al. Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors. Mol. Cell. Biol. 27, 4018–4027 (2007)
  Article CAS Google Scholar
• Westall, P. H. & Young, S. S. Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment (John Wiley, 1993)
  Google Scholar